A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy-Reference-Cited by-同舟云学术

A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy

Published:2018-05 Issue:5 Volume:267 Page:946-951
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Kuerer Henry M.,Rauch Gaiane M.,Krishnamurthy Savitri,Adrada Beatriz E.,Caudle Abigail S.,DeSnyder Sarah M.,Black Dalliah M.,Santiago Lumarie,Hobbs Brian P.,Lucci Anthony,Gilcrease Michael,Hwang Rosa F.,Candelaria Rosalind P.,Chavez-MacGregor Mariana,Smith Benjamin D.,Arribas Elsa,Moseley Tanya,Teshome Mediget,Miggins Makesha V.,Valero Vicente,Hunt Kelly K.,Yang Wei T.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference14 articles.

1. Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials;van la Parra;Breast Cancer Res,2016

2. Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial;Gianni;Lancet Oncol,2012

3. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer;Dominici;Cancer,2010

4. Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017;De Los Santos;Cancer,2013

5. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy;Peintinger;Ann Surg Oncol,2006

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer;Annals of Surgical Oncology;2024-07-24

2. On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer;2024-06-26

3. Omission of breast surgery in selected breast cancer patients with excellent response to neoadjuvant systemic therapy;European Journal of Surgical Oncology;2024-06

4. Omission of Breast Surgery in Exceptional Responders;Clinical Breast Cancer;2024-06

5. Axillary Management: How Much Is Too Much?;Current Oncology Reports;2024-05-15